Grade @ or greater adverse events were more common in the chlorambucil plus ofatumumab group ( @ -LSB- @ % -RSB- patients ; vs @ -LSB- @ % -RSB- given chlorambucil alone ) , with neutropenia being the most common event ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) .